« Back

Conor Medsystems Announces 2004 Financial Results Conference Call

MENLO PARK, Calif., March 28, 2005 /PRNewswire-FirstCall via COMTEX/ - Conor Medsystems, Inc. (Nasdaq: CONR) today announced that its 2004 financial results will be released Thursday, March 31, 2005 before the market opens and will be followed by a conference call at 1:00 PM Eastern Time. Frank Litvack, M.D., Chairman and Chief Executive Officer, and Michael Boennighausen, Chief Financial Officer, will discuss the company's operating and financial results, clinical trial developments, product development updates, litigation currently affecting the company and other business matters.

To access the live audio broadcast or the subsequent archived recording, visit the events calendar section of the company's website located at www.conormed.com. Please log on to Conor's website several minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary. A replay of the web cast will remain at this location until such time as the company reports its financial results for the first quarter of 2005.

The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at www.fulldisclosure.com and institutional investors can access the call via www.streetevents.com.

About Conor Medsystems
Conor Medsystems, Inc. develops innovative controlled vascular drug delivery technologies, and has initially focused on the development of drug-eluting stents to treat coronary artery disease. For further information on Conor Medsystems and controlled vascular delivery, visit www.conormed.com.

SOURCE Conor Medsystems, Inc.

investors, Michael Boennighausen, Chief Financial Officer of Conor Medsystems, Inc., +1-650-614-4100; or media, Karen L. Bergman of BCC Partners, +1-650-575-1509, for Conor Medsystems, Inc.